Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21057 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL149462 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL28138343 | 1.00 | USP2 (0.61) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Ammonia Solution, Strong SCHEMBL2719059 | 0.98 | USP2 (0.59) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Water SCHEMBL3908933 | 0.98 | USP2 (0.59) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Sulfuric Acid SCHEMBL3238445 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Sulfuric Acid SCHEMBL2221135 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Phosphoric Acid SCHEMBL1696409 | 0.93 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Propylamine SCHEMBL13737874 | 0.91 | USP2 (0.52) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL3504452 | 0.88 | USP2 (0.49) | USP2SLCO1B1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5941 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747629-A2 | APOPTOSIS DETECTION | Loughborough University (GB) | 2026-05-27 | — | — | EP | claimed |
| WO-2026102141-A1 | COMPOSITIONS FOR PCSK9 GENE EDITING AND METHODS OF USING SAME FOR TREATMENT OF DISEASE | VERVE THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122012505-A | Double-stranded oligonucleotide of targeted MMP-7 gene and application thereof | 北京阿尔纳科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4534092-B1 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | IONIS PHARMACEUTICALS INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4680746-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF KIDNEY DISEASE | PYC THERAPEUTICS LIMITED (AU) | 2026-01-21 | — | — | EP | claimed |
| WO-2025224036-A1 | CHEMICALLY MODIFIED SARNA COMPOSITIONS AND METHODS OF USE | MINA THERAPEUTICS LIMITED (GB) | 2025-10-30 | — | — | WO | claimed |
| US-12421270-B2 | Oligosaccharide, preparation method therefor, composition thereof and use thereof | Yantai Dongcheng Biochemicals Co., Ltd (CN) | 2025-09-23 | — | — | US | claimed |
| EP-4616203-A1 | METHODS FOR IDENTIFYING OR QUANTITATING PEPTIDES | PrognomIQ, Inc. (US) | 2025-09-17 | — | — | EP | claimed |
| US-20250282840-A1 | METHODS OF TREATMENT USING MUTANT FGF-21 PEPTIDE CONJUGATES | 89BIO LTD. (IL) | 2025-09-11 | — | — | US | claimed |
| WO-1996019231-A1 | NOVEL DISACCHARIDE INFLAMMATION INHIBITORS AND USES THEREOF | UNIVERSITY OF ALABAMA RESEARCH FOUNDATION (US) | 1996-06-27 | — | — | WO | claimed |
| EP-0682527-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-11-22 | — | — | EP | claimed |
| WO-1995024701-A1 | STEREODIRECTED PROCESS FOR SYNTHESIS OF α-N-ACETYLGALACTOSAMINIDES | BIOMIRA, INC. (CA) | 1995-09-14 | — | — | WO | claimed |
| WO-1995017506-A9 | MEDIATORS OF CHRONIC ALLOGRAFT REJECTION | — | 1995-08-31 | — | — | WO | claimed |
| WO-1995017506-A1 | MEDIATORS OF CHRONIC ALLOGRAFT REJECTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1995-06-29 | — | — | WO | claimed |
| EP-0652769-A1 | VACCINES AGAINST METAZOAN PARASITES. | MALLINCKRODT VETERINARY INC (US) | 1995-05-17 | — | — | EP | claimed |
| WO-1994017824-A1 | CARBOHYDRATE-BASED VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1994-08-18 | — | — | WO | claimed |
| WO-1994002169-A1 | VACCINES AGAINST METAZOAN PARASITES | MALLINCKRODT VETERINARY, INC. (US) | 1994-02-03 | — | — | WO | claimed |
| EP-0572529-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1993-12-08 | — | — | EP | claimed |
| WO-1992014843-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | claimed |